Predictors in the treatment of malignant central airway obstruction with silicone stents.
Central airway obstruction
Endoscopic treatment
Malignancy
Stent
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
06 Jan 2024
06 Jan 2024
Historique:
received:
10
09
2023
accepted:
19
11
2023
medline:
7
1
2024
pubmed:
7
1
2024
entrez:
6
1
2024
Statut:
aheadofprint
Résumé
To examine the role of the silicone stent in palliation of malignant central airway obstruction and identify potential preprocedural predictors for postprocedural outcome. Patients treated with endoscopic insertion of tracheobronchial silicone stents for malignant central airway obstruction at Aarhus University Hospital from 2012 to 2022 were identified from electronic medical records. Statistical analyses were carried out to identify factors affecting Days Alive and Out of Hospital, complications and overall survival. 81 patients underwent a total of 90 tracheobronchial stent insertions. Days Alive and Out of Hospital (DAOH) for the first 30 days were affected negatively by urgent intervention, p < 0.001, preprocedural non-invasive respiratory support, p < 0.001, and preprocedural intubation, p = 0.02. Post-procedural oncological treatment was associated with a significant improved DAOH, p = 0.04. Symptomatology and lesion characteristics were not significantly associated with any impact on DAOH. Overall survival was poor (mean survival was 158 days), and only significantly affected by severe degree of dyspnea, p = 0.02, and postprocedural oncological treatment, p < 0.001. Complication where registered in 25.6% of cases within the first 30 days was observed. Procedure-related mortality was 3.7%. Based on chart annotations by an ENT-surgeon, 95% of the patients experienced relief of symptoms following stent insertion. Palliative tracheobronchial airway stenting with silicone stents is found to have a beneficial impact, more research is required for identification of predictors for postprocedural outcome based on preprocedural classifications.
Identifiants
pubmed: 38183453
doi: 10.1007/s00405-023-08365-3
pii: 10.1007/s00405-023-08365-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Dutau H et al (2020) Impact of silicone stent placement in symptomatic airway obstruction due to non-small cell lung cancer—a French multicenter randomized controlled study: the SPOC trial. Respiration 99(4):344–352
doi: 10.1159/000506601
pubmed: 32213777
Nagano H et al (2017) Indications of airway stenting for severe central airway obstruction due to advanced cancer. PLoS ONE 12(6):e0179795
doi: 10.1371/journal.pone.0179795
pubmed: 28651011
pmcid: 5484493
Razi SS et al (2010) Timely airway stenting improves survival in patients with malignant central airway obstruction. Ann Thorac Surg 90(4):1088–1093
doi: 10.1016/j.athoracsur.2010.06.093
pubmed: 20868793
Oki M, Saka H, Hori K (2017) Airway stenting in patients requiring intubation due to malignant airway stenosis: a 10-year experience. J Thorac Dis 9(9):3154–3160
doi: 10.21037/jtd.2017.08.77
pubmed: 29221291
pmcid: 5708491
Routila J et al (2021) Tracheobronchial stents in patients with malignant airway disease: Finnish tertiary care experience. Interact Cardiovasc Thorac Surg 33(4):557–563
doi: 10.1093/icvts/ivab147
pubmed: 34021347
pmcid: 8691678
Iyoda A et al (2021) Contributions of airway stent for long-term outcome in patients with malignant central airway stenosis or obstruction. J Bronchology Interv Pulmonol 28(3):228–234
doi: 10.1097/LBR.0000000000000749
pubmed: 33492025
Ost DE et al (2015) Complications following therapeutic bronchoscopy for malignant central airway obstruction: results of the AQuIRE Registry. Chest 148(2):450–471
doi: 10.1378/chest.14-1530
pubmed: 25741903
pmcid: 4524328
Barros Casas D et al (2014) Non-malignant central airway obstruction. Arch Bronconeumol 50(8):345–354
doi: 10.1016/j.arbres.2013.12.012
pubmed: 24703501
Gompelmann D et al (2013) Self-expanding Y stents in the treatment of central airway stenosis: a retrospective analysis. Ther Adv Respir Dis 7(5):255–263
doi: 10.1177/1753465813489766
pubmed: 23823488
Karush JM et al (2017) Durability of silicone airway stents in the management of benign central airway obstruction. Lung 195(5):601–606
doi: 10.1007/s00408-017-0023-4
pubmed: 28623537
Iyoda A et al (2021) Long-term survival of airway silicone stents in patients with central airway stenosis or obstruction due to thoracic malignancy. Gen Thorac Cardiovasc Surg 69(9):1303–1307
doi: 10.1007/s11748-021-01634-0
pubmed: 33846932
Lachkar S et al (2020) Self-expanding metallic Y-stent compared to silicone Y-stent for malignant lesions of the main carina: a single center retrospective study. Respir Med Res 78:100767
pubmed: 32498021
Sökücü SN et al (2020) Comparison of silicon and metallic bifurcated stents in patients with malignant airway lesions. Clin Respir J 14(3):198–204
doi: 10.1111/crj.13114
pubmed: 31793225
Ortiz-Comino RM et al (2021) Silicone stent versus fully covered metallic stent in malignant central airway stenosis. Ann Thorac Surg 111(1):283–289
doi: 10.1016/j.athoracsur.2020.04.141
pubmed: 32589886
Majid A et al (2023) Stent evaluation for expiratory central airway collapse: does the type of stent really matter? J Bronchology Interv Pulmonol 30(1):37–46
doi: 10.1097/LBR.0000000000000842
pubmed: 35318996
Oki M et al (2022) Changes in pulmonary function test results and respiratory symptoms before and after airway stent removal. Respiration 101(10):925–930
doi: 10.1159/000525783
pubmed: 35878595
Freitag L et al (2007) A proposed classification system of central airway stenosis. Eur Respir J 30(1):7–12
doi: 10.1183/09031936.00132804
pubmed: 17392320
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 15273542
pmcid: 1360123
Jerath A, Austin PC, Wijeysundera DN (2019) Days alive and out of hospital: validation of a patient-centered outcome for perioperative medicine. Anesthesiology 131(1):84–93
doi: 10.1097/ALN.0000000000002701
pubmed: 31094760
Bell M et al (2019) Days at home after surgery: an integrated and efficient outcome measure for clinical trials and quality assurance. EClinicalMedicine 11:18–26
doi: 10.1016/j.eclinm.2019.04.011
pubmed: 31317130
pmcid: 6610780
Myles PS et al (2017) Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia. BMJ Open 7(8):e015828
doi: 10.1136/bmjopen-2017-015828
pubmed: 28821518
pmcid: 5629653